Shuttle Pharmaceuticals Reports Director/Officer Changes & Shareholder Votes

Ticker: SHPH · Form: 8-K · Filed: May 15, 2025 · CIK: 1757499

Shuttle Pharmaceuticals Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyShuttle Pharmaceuticals Holdings, Inc. (SHPH)
Form Type8-K
Filed DateMay 15, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes, shareholder-vote

TL;DR

Shuttle Pharma's 8-K: Board shakeup, new execs, and shareholder votes on the way.

AI Summary

Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on May 15, 2025, reporting events as of May 9, 2025. The filing covers the departure of directors, election of directors, appointment of officers, and compensatory arrangements. It also includes the submission of matters to a vote of security holders.

Why It Matters

Changes in board composition and officer appointments can signal shifts in company strategy or governance, while shareholder votes directly impact corporate decisions.

Risk Assessment

Risk Level: medium — Changes in directors and officers, along with shareholder votes, can indicate internal shifts or upcoming strategic decisions that may impact the company's future performance.

Key Players & Entities

  • Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
  • Delaware (jurisdiction) — State of incorporation
  • Gaithersburg, MD (location) — Principal executive offices address

FAQ

What specific items were submitted to a vote of security holders?

The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.

Who are the newly appointed officers or departing directors mentioned in the filing?

The filing states that there were departures of directors and appointments of certain officers, but the names of these individuals are not specified in the provided text.

What is the exact date of the earliest event reported in this 8-K?

The earliest event reported in this 8-K is dated May 9, 2025.

What is the SEC file number for Shuttle Pharmaceuticals Holdings, Inc.?

The SEC file number for Shuttle Pharmaceuticals Holdings, Inc. is 001-41488.

What is the business address of Shuttle Pharmaceuticals Holdings, Inc.?

The business address of Shuttle Pharmaceuticals Holdings, Inc. is 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.